REED REED'S, INC.
NYSE · SEC CIK 1140215 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $0 0 sales by 0 insiders
- Filings on record
- 29 since 2021-08-24, latest 2025-06-11
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| No open-market trades in the last year. | |||
Transactions 28
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2025-06-11 | 2025-06-04 | REED | Era Regenerative Medicine Ltd | 10% | P - Purchase | — | +1.08M | 28.21M | +4% | — |
| I | 2025-01-28 | 2024-12-31 | REED | DENG Shufen | Dir | J - Other | $0.00 | -27.14M | 0 | -100% | $0 |
| I | 2024-12-06 | 2024-11-19 | REED | D&D Source of Life Holding Ltd. | 10% | J - Other | $1.00 | +22.48M | 27.14M | +482% | +$22.48M |
| MI | 2024-11-18 | 2024-11-14+ | REED | Zaltzman Leon Michael | 10% | S - Sale | $1.12 | -10.5K | 1.22M | -0.9% | -$11.8K |
| 2024-10-08 | 2024-09-10 | REED | Bello John | Dir | C - Cnv Deriv | $1.50 | +200.0K | 258.8K | +340% | +$300.0K | |
| I | 2024-09-24 | 2024-09-10 | REED | Zaltzman Leon Michael | 10% | P - Purchase | $1.50 | +531.2K | 1.23M | +76% | +$796.8K |
| DMI | 2024-09-13 | 2023-05-25+ | REED | D&D Source of Life Holding Ltd. | 10% | P - Purchase | $1.79 | +4.43M | 1.16M | New | +$7.91M |
| D | 2024-06-10 | 2024-04-29 | REED | Burleson Christopher Scott | CCO | P - Purchase | — | +5,209 | 29.4K | +22% | — |
| D | 2024-05-09 | 2024-04-29 | REED | Tinnelly Joann Christine | CFO | P - Purchase | — | +17.3K | 38.0K | +84% | — |
| D | 2024-05-09 | 2024-04-29 | REED | Snyder Norman E. Jr. | CEO, Dir | P - Purchase | — | +37.6K | 99.9K | +60% | — |
| I | 2023-12-13 | 2023-12-06 | REED | Bello John | Dir, 10% | P - Purchase | $1.80 | +5,000 | 385.2K | +1% | +$9,000 |
| 2023-12-01 | 2023-11-28 | REED | Burleson Christopher Scott | CCO | A - Grant | — | +18.2K | 24.2K | +303% | — | |
| I | 2023-11-29 | 2023-11-28 | REED | Bello John | Dir, 10% | P - Purchase | $2.04 | +5,000 | 380.2K | +1% | +$10.2K |
| DI | 2023-06-01 | 2023-05-25 | REED | Union Square Park GP, LLC | 10% | P - Purchase | — | +193.4K | 699.5K | +38% | — |
| DI | 2023-06-01 | 2023-05-25 | REED | Bello John | Dir, 10% | P - Purchase | — | +193.4K | 375.2K | +106% | — |
| I | 2022-12-19 | 2022-12-16 | REED | Bello John | Dir | P - Purchase | $0.07 | +250.0K | 1.24M | +25% | +$17.5K |
| I | 2022-11-25 | 2022-11-22 | REED | Bello John | Dir | P - Purchase | $0.1 | +250.0K | 5.86M | +4% | +$25.0K |
| 2022-07-27 | 2022-06-30 | REED | Kosler Thomas Wayne | Dir | A - Grant | — | +40.2K | 40.2K | New | — | |
| D | 2022-05-18 | 2022-03-11 | REED | Snyder Norman E. Jr. | CEO, Dir | P - Purchase | — | +285.6K | 1.61M | +21% | — |
| 2022-05-05 | 2022-02-04 | REED | JAFFE LEWIS | Dir | A - Grant | — | +80.3K | 399.6K | +25% | — | |
| D | 2022-04-18 | 2022-03-11 | REED | Imbrogno Louis Jr. | Dir | P - Purchase | — | +107.1K | 427.2K | +33% | — |
| D | 2022-04-18 | 2022-02-04 | REED | Imbrogno Louis Jr. | Dir | A - Grant | — | +80.3K | 320.1K | +34% | — |
| 2022-04-18 | 2022-02-04 | REED | Bass James C | Dir | A - Grant | — | +80.3K | 556.9K | +17% | — | |
| 2022-04-06 | 2022-02-04 | REED | Kallman Rhonda | Dir | A - Grant | — | +80.3K | 80.3K | New | — | |
| 2021-10-01 | 2021-09-30 | REED | Spisak Thomas J. | CFO | P - Purchase | $0.6 | +16.0K | 380.7K | +4% | +$9,600 | |
| 2021-10-01 | 2021-09-29 | REED | Snyder Norman E. Jr. | CEO, Dir | P - Purchase | $0.59 | +50.0K | 1.05M | +5% | +$29.5K | |
| I | 2021-09-16 | 2021-09-15 | REED | Bello John | Dir | P - Purchase | $0.56 | +100.0K | 3.77M | +3% | +$56.0K |
| I | 2021-08-24 | 2021-08-16 | REED | Bello John | Dir | P - Purchase | $0.72 | +135.0K | 3.67M | +4% | +$97.2K |
Purchase Sale Sale after option exercise All abbreviations